Update on Outcome Measure Development for Large Vessel Vasculitis: Report from OMERACT 12

OBJECTIVE: The rarity of large vessel vasculitis (LVV) is a major factor limiting randomized controlled trials in LVV, resulting in treatment choices in these diseases that are guided mainly by observational studies and expert opinion. Further complicating trials in LVV is the absence of validated a...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Rheumatol
Main Authors: Aydin, Sibel Zehra, Direskeneli, Haner, Sreih, Antoine, Alibaz-Oner, Fatma, Gul, Ahmet, Kamali, Sevil, Hatemi, Gulen, Kermani, Tanaz, Mackie, Sarah L., Mahr, Alfred, Meara, Alexa, Milman, Nataliya, Nugent, Heidi, Robson, Joanna, Tomasson, Gunnar, Merkel, Peter A.
Formato: Artigo
Idioma:Inglês
Publicado: 2015
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4668221/
https://ncbi.nlm.nih.gov/pubmed/26077399
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3899/jrheum.141144
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares